Julie Hambleton - Insider Trading & Ownership

Entity
Individual
Location
C/O Five Prime Therapeutics, Inc., Two Corporate Drive, South San Francisco, California
Summary
The estimated net worth of Julie Hambleton is at least $172 K dollars as of June 21, 2024. Julie Hambleton is the Director of SpringWorks Therapeutics, Inc. and owns shares of SpringWorks Therapeutics, Inc. (SWTX) stock worth about $172 K.
All Insider Reports
All Insider Reports

Ownership of Julie Hambleton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SWTX SpringWorks Therapeutics, Inc. Director $172 K -$257 K -59.8% Jun 3, 2024
ERAS Erasca, Inc. Director Jun 20, 2024
IGMS IGM Biosciences, Inc. Director Mar 12, 2024

Insider Transactions Reported by Julie Hambleton:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership